Seroprevalence of SARS-CoV-2 in two penitentiary institutions in Paraguay in the period April-May 2022
DOI:
https://doi.org/10.53732/rccsalud/2024.e6145Keywords:
seroepidemiologic studies, antibodies, SARS-CoV-2, prisons, ParaguayAbstract
Introduction. The COVID-19 pandemic has exposed many of the inequalities in society and one of the most neglected vulnerable populations are those deprived of their liberty. Objective. Determine the seroprevalence of SARS-CoV-2 in the population deprived of liberty (PDL) in two penitentiary institutions in Paraguay between April-May 2022. Materials and methods. Cross-sectional descriptive study in two penitentiary institutions in Paraguay, one for men and the other one for women, using two-stage probabilistic sampling. The blood samples were taken by fingerprint for the determination of anti-SARS-CoV-2 antibodies by a rapid IgG/IgM test (Orient Gene Biotech COVID-19 cassette). Descriptive statistics (mean, standard deviation (SD), percentages) and analytical statistics (chi square test) were used for data analysis. Results. A total of 602 PDL were included, 67% men and 33% women, the average age was 34 years (SD 10.71), 21% (n=124) with comorbidity, 31% (n=186) with complete vaccination. Of the 66 PPL (11%) who reported prior Covid-19 infection, 79% (n=52) developed symptoms and 6% (n=4) required hospitalization. In men, 95% presented positive serology (IgG and/or IgM) for SARS-CoV-2 (95% CI: 92.18-96.58) and 94% (95% CI: 89.65-96.83) in women. In the vaccinated group, seropositivity was 98.5% (95% CI: 97.11-99.25), and among the unvaccinated, 57% (95% CI: 53.22-70.29). Conclusion. The seroprevalence of SARS-CoV-2 was similar to that reported in other studies. The structural unhealthiness and overcrowding are factors that enhance the spread of the virus and emphasize the importance of encouraging vaccination in these populations.
References
Arocena GA. COVID-19 y cárceles argentinas. 2020.
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19. 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
World Health Organization. 2019 Novel Coronavirus (2019-nCoV): Strategic preparedness and response plan. WHO. 2020. https://www.who.int/publications-detail-redirect/strategic-preparedness-and-response-plan-for-the-new-coronavirus
World Health Organization. Good governance for prison health in the 21st century: a policy brief on the organization of prison health. WHO. 2013. https://www.who.int/europe/publications/i/item/9789289000505
Cutts FT, Hanson M. Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries. Trop Med Int Health. 2016;21(9):1086-98. https://doi.org/10.1111/tmi.12737
Cardeñosa Marín N. Estudios seroepidemiológicos. Rev. Esp. Salud Publica. 2009;83(5):607-10. https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1135-57272009000500002
Barallat J, Fernández-Rivas G, Quirant-Sánchez B, González V, Doladé M, Martinez-Caceres E, et al. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave. PLoS One. 2020;15(12):e0244348. https://doi.org/10.1371/journal.pone.0244348
López Jiménez X. Derecho al trato humano a las personas privadas de libertad. Una crisis dentro de otra. DDHHpy. 2020. https://codehupy.org.py/ddhh2020/una-crisis-dentro-de-otra/
Oficina de las Naciones Unidas contra la Droga y el Delito. Documento de posición. Preparación y respuestas para la COVID-19 en las cárceles. UNODC. https://www.unodc.org/documents/justice-and-prison-reform/COVID-19/20-02218_Position_paper_ES.pdf
Varela. L- Cárceles inhumanas, aptas para delinquir. Sistema penitenciario. https://bibliotecavirtual.clacso.org.ar/ar/libros/paraguay/cde/cde2002/penitenciario2002.pdf
Ministerio de Salud Pública y Bienestar Social. Disminuyen casos de COVID-19 en sistema penitenciario. MSYPYBS. 2020. https://www.mspbs.gov.py/portal/21769/disminuyen-casos-de-covid-19-en-sistema-penitenciario.html
Kronfli N, Dussault C, Maheu-Giroux M, Halavrezos A, Chalifoux S, Sherman J, et al. Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Quebec, Canada 2021. Clin Infect Dis. 2022;75(1):e165-173. https://doi.org/10.1093/cid/ciac031
Assistance Publique - Hôpitaux de Paris (Responsible Party). Assessment of SARS-CoV-2 Seroprevalence in Detention (COVIDET). 2021. https://clinicaltrials.gov/ct2/show/NCT04516512
Silva AI da, Maciel ELN, Duque CLC, Gomes CC, Bianchi E do N, Cardoso OA, et al. Prevalence of COVID-19 infection in the prison system in Espírito Santo/Brazil: persons deprived of liberty and justice workers. Rev Bras Epidemiol. 2021;24:e210053. https://doi.org/10.1590/1980-549720210053
Casos de COVID-19 en Rikers Island superan cifra récord del 37% de tasa de positividad. El Diario NY. 2022. https://eldiariony.com/2022/01/04/casos-de-covid-19-en-rikers-island-superan-cifra-record-del-37-de-tasa-de-positividad/
Cabello A, Samudio M, Sequera G, Ocampos Sandra, Galeano Rosa, Vázquez C. Infección por COVID19: estudio seroepidemiológico de cohorte de base poblacional, estratificado por edad, en Asunción y Central. Rev. chil. infectol. 2022;39(3):238-247. http://dx.doi.org/10.4067/s0716-10182022000200238
Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020;92(9):1518-24. https://doi.org/10.1002/jmv.25727
Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. The Lancet. 2020;396(10250):535-44. https://doi.org/10.1016/s0140-6736(20)31483-5
Hoffman T, Nissen K, Krambrich J, Rönnberg B, Akaberi D, Esmaeilzadeh M, et al. Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2. Infect Ecol Epidemiol. 2020;10(1):1754538. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178815/
COVID-19 IgG/IgM Rapid Test Kit (Sangre/Suero/Plasma) Para Uso Profesional. https://www.diba.cat/documents/306225111/308327917/Instruccions+d%27%C3%BAs.pdf/34620ab9-e97e-4ee1-a580-81c09449b34a.
WMA - The World Medical Association-Declaración de Helsinki de la AMM – Principios éticos para las investigaciones médicas en seres humanos. https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
Bianchi E do N, Macedo LR, Maciel ELN, Sá RT, Silva AI da, Duque CLC, et al. Prevalência de infecção por SARS-CoV-2 e fatores associados em pessoas privadas de liberdade no Espírito Santo, Brasil. Cad Saúde Pública 2022;38(2). https://doi.org/10.1590/0102-311X00094721
Rafael-Heredia A, Iglesias-Osores S, Saavedra-Camacho JL, Bocanegra-Mozombite JJ, Leveau-Bartra WR, Leveau-Bartra OA, Córdova-Rojas LM. Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon. SciELO Preprints. 2022. https://doi.org/10.1590/SciELOPreprints.3828
Wallace M, Hagan L, Curran KG, Williams SP, Handanagic S, Bjork A, et al. COVID-19 in Correctional and Detention Facilities - United States, February-April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(19):587-90. https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6919e1-H.pdf?deliveryName=USCDC_921-DM27552
Sindeev A, Martínez-Álvarez BM, Sindeev A, Martínez-Álvarez BM. Características clínico-epidemiológicas de los reclusos infectados y fallecidos por COVID-19, según datos del Instituto Nacional Penitenciario del Perú de 2020. Rev esp sanid. penit. 2022;24(1):15-22. https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1575-06202022000100015
Marco A, Guerrero RA, Turu E. El control de la infección por SARS-CoV-2 en prisiones. Semergen. 2021;47(1):47-55. https://doi.org/10.1016/j.semerg.2020.10.009
Yagüe-Olmos C, Cabello-Vázquez MI. Programa de deshabituación tabáquica para internos y trabajadores de un centro penitenciario. Rev esp. Sanid. penit. 2008;10(2):57-64. https://scielo.isciii.es/pdf/sanipe/v10n2/especial.pdf
Cossetin-Costa M, Mantovani M, Moura-D'Almeida-Miranda F, Carneiro-Mussi F, da Silva-Pires CG. Características sociodemográficas, hábitos de vida y condiciones de salud de las personas privadas de libertad. Enferm. glob.; 2022(72):26-76.
https://doi.org/10.6018/eglobal.558881
Acosta VSM, Cattebeke PV, Rojas NR, Vargas FC. Tabaquismo entre las internas de un centro penitenciario para mujeres. An. Fac. Cienc. Méd. 2019;52(2):49-52. https://doi.org/10.18004/anales/2019.052(02)49-052
Richmond RL, Butler T, Belcher JM, Wodak A, Wilhelm KA, Baxter E. Promoting smoking cessation among prisoners: feasibility of a multi-component intervention. Aust N Z J Public Health. 2006;30(5):474-8. https://doi.org/10.1111/j.1467-842X.2006.tb00467.x
Jayes LR, Murray RL, Opazo Breton M, Hill C, Ratschen E, Britton J. Smoke-free prisons in England: indoor air quality before and after implementation of a comprehensive smoke-free policy. 2019;9:e025782. BMJ Open. https://doi.org/10.1136/bmjopen-2018-025782
.png)
All the contents of this journal are licensed under a 